Showing results (1471-1480 of 26,316) with videos related to

Sort By:
Pageof 2,632
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide seriesScott D Kuduk, Robert M DiPardo, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Highly potent growth hormone secretagoguesZhijian Lu, James R Tata, Kang Cheng, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safetyTimothy I Richardson, Scott A Frank, Minmin Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonistsWilliam A Carroll, Douglas M Kalvin, Arturo Perez Medrano, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2007
Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Christopher McGuigan, Andrea Brancale, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2007
3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonistsShu-Hai Zhao, Jacob Berger, Robin D Clark, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2007
Paclitaxel C-10 carbamates: potential candidates for the treatment of neurodegenerative tauopathiesCarlo Ballatore, Edward Hyde, Robert F Deiches, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2022
Synthesis and in vivo evaluation of [11C]tucatinib for HER2-targeted PET imagingMarius Müller, Vladimir Shalgunov, Lars Hvass, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2022
Design, synthesis, and bioactivity evaluation of novel 1-(4-(benzylsulfonyl)-2-nitrophenyl) derivatives as potential anti-inflammatory agents against LPS-induced acute lung injuryPan Chen, Yiming Yu, Sijia Su, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2022
Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino [2,3-f]quinazolin derivatives as EGFR-TKIsXuemei Qin, Peng Liu, Yihai Li, et al.
Pageof 2,632